Molecular Predictors of Lung Cancer Behavior: Controls
- To obtain biological specimens from healthy participants with no known risk of lung
cancer to use as controls in the study of lung cancer progression.
- To identify new molecular abnormalities specific to the development of squamous cell
carcinoma of the lung.
OUTLINE: Serum, urine, sputum, and buccal cell samples are collected. Patients also undergo
bronchoscopy for collection of bronchial tissue and bronchial brush samples. The samples are
used for genomic and proteomic studies to identify new molecular abnormalities specific to
the development of lung cancer.
Observational Model: Cohort, Time Perspective: Prospective
Collection of biological specimens to use as controls in the study of lung cancer progression
Specimens are collected from healthy participants with no known risk of lung cancer
Off study date, up to one year
Pierre P. Massion, MD
Vanderbilt-Ingram Cancer Center
United States: Vanderbilt University Human Research Protection Program
|Vanderbilt-Ingram Cancer Center||Nashville, Tennessee 37232-6838|
|Vanderbilt-Ingram Cancer Center - Cool Springs||Nashville, Tennessee 37064|
|Vanderbilt-Ingram Cancer Center at Franklin||Nashville, Tennessee 37064|